Modern Diagnostic & Research Centre SME IPO
Modern Diagnostic & Research Centre IPO — date, price band, GMP & allotment 2025
Modern Diagnostic & Research Centre offers advanced diagnostic, imaging, and laboratory services across healthcare sectors. The IPO will support facility expansion, new technology acquisition, and service network growth. With rising healthcare demand in India, Modern Diagnostic & Research Centre aims to deliver quality diagnostics and research services, giving investors exposure to the healthcare and medical diagnostics segment.
Stock price
Modern Diagnostic & Research Centre is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 11 September.
- Open 31 Dec 2025
- Close 02 Jan 2026
- Allotment 05 Jan 2026
- Refund/credit 06 Jan 2026
- Listing 07 Jan 2026
Issue summary
The terms of the offer, as filed.
| IPO Dates | 31 Dec to 2 Jan, 2026 |
|---|---|
| Price Band | ₹85 to 90 |
| Face Value | ₹₹10 |
| Lot Size | 1600 Shares |
| Issue Size | ₹0.41 Cr. Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE SME |
| Employee Discount | NA |
| Registrar | MUFG Intime India Private Limited |
| Min Investment | ₹ 2,88,000 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 1600 shares at the ₹90 cut-off. The SME retail application is a fixed 2 lots; HNI starts at 3.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 2 | 3,200 | ₹2,88,000 |
| Retail (max) | 2 | 3,200 | ₹2,88,000 |
| HNI (min) | 3 | 4,800 | ₹4,32,000 |
Three years of numbers
All figures in ₹ crore, as reported in the Modern Diagnostic & Research Centre offer document.
| Metric | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 77.86 | 64.57 | 49.49 | 36.54 |
| Total Income | 22.67 | 78.80 | 68.67 | 56.61 |
| Profit After Tax | 3.00 | 8.97 | 5.79 | -5.73 |
| EBITDA | 5.86 | 17.96 | 11.05 | -0.99 |
| NET Worth | 23.72 | 20.73 | 11.76 | 5.96 |
| Reserves and Surplus | 12.72 | 9.73 | 10.76 | 4.96 |
| Total Borrowing | 30.38 | 22.09 | 20.46 | 15.31 |
See how this IPO compares — view listing performance of all SME IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Modern Diagnostic & Research Centre RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Modern Diagnostic & Research Centre IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Post-Issue |
|---|---|
| EPS (₹) | ₹7.94 |
| P/E Ratio (x) | 11.33 |
| Market Cap at Offer Price (₹ Cr) | ₹34.01 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹90 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
₹33.02 Cr of the issue is earmarked to named objects.
About the company
The company offers a wide range of services including pathology testing, radiology services such as X-ray, ultrasound, and other specialised diagnostic solutions. Its business model is centred around operating diagnostic centres and laboratories, generating revenue through test-based services and partnerships with hospitals and clinics. With a focus on customer trust, affordability, and expansion into new locations, the company continues to strengthen its footprint in the healthcare diagnostics sector.
Interested in this IPO? Check the live subscription status or browse all upcoming SME IPOs.
9999474297
The bankers & the filings
Who is running the book, and the documents this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Beeline Capital Advisors Pvt. Ltd.
3 issues handled (1 mainboard, 2 SME)2 of their issues have listed so far, and 2 opened above the issue price (average +24.3%). That is too small a sample to read as a hit rate.
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Modern Diagnostic & Research Centre?
The current Grey Market Premium is ₹14, or 16% over the issue price.
What is the Modern Diagnostic & Research Centre IPO price band?
₹85 to ₹90, on a face value of ₹₹10.
When is the allotment?
The basis of allotment is 5 January 2026, with listing on 7 January 2026.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — MUFG Intime India Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every SME and Mainboard issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
